Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
In a landmark decision, the court has preliminarily approved settlement agreements in the commission lawsuits involving real estate companies RE/MAX and Anywhere Real Estate. The agreements require RE/MAX to pay $55 million and Anywhere Real Estate to pay $83.5 million. As part of the settlements, both companies will implement significant policy and practice changes, including the elimination of the requirement for agents to be members of the National Association of Realtors. This change will provide agents with more flexibility and independence in their business practices. The settlements have far-reaching implications for the real estate industry, fostering a more dynamic and customer-centric real estate market.
The housing market saw a remarkable increase in housing starts and permits in October, pointing to a positive industry trend. This surge suggests a growing demand among Americans for homeownership, prompting builders to respond by ramping up their construction efforts. However, builder confidence has been somewhat dampened by elevated mortgage rates. The housing market's performance varied across different regions in the United States, highlighting the diverse nature of the housing market and the various factors influencing construction trends.
CUSO Home Lending has implemented Dark Matter Technologies' advanced Empower loan origination system, revolutionizing the credit union lending process. The Empower system streamlines loan applications, automates document collection and verification, and facilitates seamless communication between borrowers, loan officers, and underwriters. With robust security measures and full compliance with industry regulations, the system ensures the protection of sensitive information. This move highlights the importance of embracing digital transformation in the lending industry.
United Wholesale Mortgage (UWM), a leading wholesale lender in the mortgage industry, has launched a new initiative offering no-cost appraisals on 1-0 temporary rate buydowns. This strategic move aims to attract more brokers by covering up to $600 of the appraisal cost on all conventional and government-backed home loans. Temporary rate buydowns allow borrowers to pay a lower mortgage rate during the initial period of their loans, making homeownership more affordable. This limited-time opportunity until March 31 provides brokers with a unique value proposition for their clients. Ready to explore the benefits of UWM's temporary rate buydowns and no-cost appraisals? Connect with UWM today.
Mark Willis has made a significant leadership change by returning as the CEO of Keller Williams, a leading player in the real estate industry. This news marks a triumphant comeback for Willis, who previously served as the CEO of Keller Williams from 2005 to 2014. Armed with extensive experience and a proven track record, Willis aims to steer Keller Williams towards continued success and navigate the challenges facing the real estate industry. This article will delve into Willis' career history, the growth of Keller Williams under his leadership, and the current landscape of the real estate market.
A recent lawsuit in Texas has sent shockwaves through the real estate industry, shedding light on alleged collusion among individual brokers, real estate teams, and large corporate brokerages. The lawsuit, filed by the QJ Team and other plaintiffs, accuses these entities of artificially inflating real estate agent commissions. The real estate industry has been rocked by a series of commission lawsuits in recent years, but the QJ Team lawsuit stands out due to its comprehensive list of defendants. The QJ Team lawsuit alleges that the defendants engaged in collusion to artificially inflate real estate agent commissions, thereby restricting competition and harming consumers. The plaintiffs claim that these entities conspired to set and maintain high commission rates, limiting the ability of homebuyers and sellers to negotiate fair prices. If proven true, these allegations could have far-reaching consequences for the real estate industry in Texas.
